Business of Medicine
Latest News
Vision screening at well-child visits cost-effective for detecting amblyopia
Because the study only assesses amblyopia, and not all eye diseases and disorders, the cost-effectiveness of optometric eye exams may be...
Feature
Singer is paralyzed after delay in care; hospital must pay
In a suit, the singer alleged that a doctor had probably ‘nicked a blood vessel’ during an epidural steroid injection procedure, causing...
From the Journals
Pandemic may be limiting ED access for sexual assault
As the COVID-19 pandemic continued, ‘we became increasingly concerned about limited health care access for survivors of sexual assault,’ said the...
Commentary
A remote mountain bike crash forces a doctor to take knife in hand
An emergency medicine doctor stops mountain biking to help a man lying on a trail, not moving but occasionally breathing.
Feature
Arkansas cardiologist pays $900K to settle false claims allegations
As part of the settlement, the doctor will enter into an integrity agreement with the US Department of Health & Human Services.
Feature
What to do when patients don’t listen
The reasons behind a patient’s nonadherence are multifaceted.
Commentary
Age competency exams for physicians – yes or no?
Almost one-third of licensed doctors in the United States were 60 years of age or older, according to a survey conducted in 2020.
From the Journals
Little-used fitness measure could be key to exercise results
A new study suggests doctors could take that initiative to the next level, prescribing exercise plans that result in a specific health outcome.
From the Journals
‘Low-value’ prostate cancer screening prevalent in primary care
A new study shows that testing for prostate-specific antigen and also digital rectal examinations are both carried out frequently in older men.
From the Journals
Advanced Primary Care program boosts COVID-19 results
Better outcomes were seen in higher vaccination rates and fewer infections, hospitalizations, and deaths from COVID-19.
Feature
Latest steps toward reducing U.S. insulin cost begin in 2023
Beneficiaries who take insulin via pen or syringe, covered under Medicare part D, fall under the $35/month co-pay cap.